Viemed Healthcare (NASDAQ:VMD) Downgraded to “Hold” Rating by Freedom Capital

Freedom Capital lowered shares of Viemed Healthcare (NASDAQ:VMD) from a strong-buy rating to a hold rating in a research report released on Wednesday,Zacks.com reports.

Separately, Weiss Ratings upgraded Viemed Healthcare from a “hold (c+)” rating to a “buy (b-)” rating in a report on Monday. One investment analyst has rated the stock with a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat.com, Viemed Healthcare currently has an average rating of “Hold”.

Viemed Healthcare Stock Performance

Shares of VMD opened at $9.52 on Wednesday. The company has a market cap of $362.62 million, a price-to-earnings ratio of 26.45 and a beta of 1.10. The business’s fifty day simple moving average is $11.15 and its two-hundred day simple moving average is $9.75. Viemed Healthcare has a 12 month low of $6.05 and a 12 month high of $12.61. The company has a current ratio of 1.13, a quick ratio of 1.10 and a debt-to-equity ratio of 0.04.

Viemed Healthcare (NASDAQ:VMD) last posted its quarterly earnings results on Monday, August 3rd. The company reported $0.07 earnings per share for the quarter, missing the consensus estimate of $0.12 by ($0.05). The business had revenue of $78.10 million during the quarter, compared to analysts’ expectations of $78.00 million. Viemed Healthcare had a return on equity of 10.16% and a net margin of 4.81%. Research analysts anticipate that Viemed Healthcare will post 0.44 earnings per share for the current fiscal year.

Insider Activity at Viemed Healthcare

In related news, insider William Frazier sold 10,000 shares of the business’s stock in a transaction that occurred on Thursday, June 25th. The shares were sold at an average price of $11.72, for a total transaction of $117,200.00. Following the completion of the sale, the insider directly owned 73,214 shares in the company, valued at approximately $858,068.08. The trade was a 12.02% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Timothy Smokoff sold 20,000 shares of the business’s stock in a transaction that occurred on Wednesday, June 24th. The shares were sold at an average price of $11.50, for a total transaction of $230,000.00. Following the sale, the director owned 75,518 shares of the company’s stock, valued at $868,457. This trade represents a 20.94% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 20.60% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the business. North Star Investment Management Corp. bought a new position in Viemed Healthcare in the 1st quarter worth $921,000. Arrowstreet Capital Limited Partnership grew its holdings in Viemed Healthcare by 101.9% during the first quarter. Arrowstreet Capital Limited Partnership now owns 711,186 shares of the company’s stock valued at $6,550,000 after purchasing an additional 358,863 shares during the period. Hillsdale Investment Management Inc. purchased a new stake in Viemed Healthcare in the first quarter worth about $1,834,000. Lazard Asset Management LLC increased its position in Viemed Healthcare by 117.6% in the first quarter. Lazard Asset Management LLC now owns 215,938 shares of the company’s stock worth $1,989,000 after buying an additional 116,700 shares in the last quarter. Finally, Expect Equity LLC raised its stake in shares of Viemed Healthcare by 59.6% in the fourth quarter. Expect Equity LLC now owns 173,970 shares of the company’s stock worth $1,293,000 after buying an additional 64,961 shares during the period. Hedge funds and other institutional investors own 74.24% of the company’s stock.

About Viemed Healthcare

Viemed Healthcare, Inc (NASDAQ: VMD) is a provider of home-based respiratory therapy services, specializing in the management of patients requiring long-term mechanical ventilation and pulmonary support. The company’s offerings encompass invasive and noninvasive ventilation, airway clearance therapies, cough assist devices, and supplemental oxygen. Viemed combines durable medical equipment with clinical care, delivering tailored respiratory treatment plans that are overseen by licensed respiratory therapists and registered nurses.

Founded in the early 2010s and headquartered in Birmingham, Alabama, Viemed has grown its footprint to serve patients across multiple states in the United States.